In this study, we observed that the expression of CTC subpopulations CD133+CD54+CD44+ and CD133+CD26+CD44+ were significantly higher in the peripheral blood of CRC-LM patients when compared with those without liver metastasis. This evidence concerns the gene PROM1 and colorectal carcinoma.